Your browser doesn't support javascript.
loading
Novel unsaturated glycyrrhetic acids derivatives: Design, synthesis and anti-inflammatory activity.
Li, Bo; Cai, Shi; Yang, Yong-An; Chen, Shi-Chao; Chen, Rui; Shi, Jing-Bo; Liu, Xin-Hua; Tang, Wen-Jian.
Afiliación
  • Li B; School of Pharmacy, Anhui Province Key Laboratory of Major Autoimmune Diseases, Anhui Institute of Innovative Drugs, Anhui Medical University, Hefei 230032, China.
  • Cai S; School of Pharmacy, Anhui Province Key Laboratory of Major Autoimmune Diseases, Anhui Institute of Innovative Drugs, Anhui Medical University, Hefei 230032, China.
  • Yang YA; Elion Nature Biological Technology Co., Ltd, Nanjing 210038, China.
  • Chen SC; School of Pharmacy, Anhui Province Key Laboratory of Major Autoimmune Diseases, Anhui Institute of Innovative Drugs, Anhui Medical University, Hefei 230032, China.
  • Chen R; School of Pharmacy, Anhui Province Key Laboratory of Major Autoimmune Diseases, Anhui Institute of Innovative Drugs, Anhui Medical University, Hefei 230032, China.
  • Shi JB; School of Pharmacy, Anhui Province Key Laboratory of Major Autoimmune Diseases, Anhui Institute of Innovative Drugs, Anhui Medical University, Hefei 230032, China.
  • Liu XH; School of Pharmacy, Anhui Province Key Laboratory of Major Autoimmune Diseases, Anhui Institute of Innovative Drugs, Anhui Medical University, Hefei 230032, China. Electronic address: xhliuhx@163.com.
  • Tang WJ; School of Pharmacy, Anhui Province Key Laboratory of Major Autoimmune Diseases, Anhui Institute of Innovative Drugs, Anhui Medical University, Hefei 230032, China. Electronic address: ahmupharm@126.com.
Eur J Med Chem ; 139: 337-348, 2017 Oct 20.
Article en En | MEDLINE | ID: mdl-28803048
ABSTRACT
To develop novel anti-inflammatory agents, a series of unsaturated glycyrrhetic acids were designed, synthesized and evaluated for anti-inflammatory activity using RAW264.7 cells. The structure-activity relationship (SAR) of NO inhibitory activity was analyzed. α,ß-Unsaturated glycyrrhetic acids showed better activity, among them, compounds 6k and 6l with piperazine unit exhibited the most potent nitric oxide (NO) and interleukin-6 (IL-6) inhibitory activity (IC50 = 13.3 and 15.5 µM respectively). Furthermore, compound 6k could also significantly suppress LPS-induced iNOS and COX-2 expression and IL-6 production through MAPKs and NF-kB signaling pathway.
Asunto(s)
Palabras clave

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Diseño de Fármacos / Antiinflamatorios no Esteroideos / Interleucina-6 / Ácido Glicirretínico / Óxido Nítrico Tipo de estudio: Prognostic_studies Idioma: En Revista: Eur J Med Chem Año: 2017 Tipo del documento: Article

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Diseño de Fármacos / Antiinflamatorios no Esteroideos / Interleucina-6 / Ácido Glicirretínico / Óxido Nítrico Tipo de estudio: Prognostic_studies Idioma: En Revista: Eur J Med Chem Año: 2017 Tipo del documento: Article